sCD163 and sMR in Wilsons Disease - Associations With Disease Severity and Fibrosis
Status:
Active, not recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
The aim is to investigate macrophage activation markers and correlations to liver fibrosis in
patients with Wilsons Disease. Researchers wish to investigate associations to neurologic and
metabolic liver function. Researchers will assess this by comparing blood samples with
fibrosis and liver function analyses. This study provides new insight into macrophages and
their involvement in Wilsons Disease.